These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21665546)

  • 21. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
    Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
    Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of serum and follicular fluid hormone levels with recombinant and urinary human chorionic gonadotropin during in vitro fertilization.
    Kovacs P; Kovats T; Bernard A; Zadori J; Szmatona G; Kaali SG
    Fertil Steril; 2008 Dec; 90(6):2133-7. PubMed ID: 18177866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
    Lahoud R; Al-Jefout M; Tyler J; Ryan J; Driscoll G
    Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of gonadotropin-releasing hormone agonist/recombinant follicle-stimulating hormone versus gonadotropin-releasing hormone antagonist/recombinant follicle-stimulating hormone on follicular fluid levels of adhesion molecules during in vitro fertilization.
    Fornaro F; Cobellis L; Mele D; Tassou A; Badolati B; Sorrentino S; De Lucia D; Colacurci N
    Fertil Steril; 2007 Jan; 87(1):39-47. PubMed ID: 17084393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial.
    De Placido G; Alviggi C; Perino A; Strina I; Lisi F; Fasolino A; De Palo R; Ranieri A; Colacurci N; Mollo A;
    Hum Reprod; 2005 Feb; 20(2):390-6. PubMed ID: 15576390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection.
    Kyrou D; Kolibianakis EM; Fatemi HM; Camus M; Tournaye H; Tarlatzis BC; Devroey P
    Fertil Steril; 2011 Oct; 96(4):884-8. PubMed ID: 21843888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late Follicular Phase Ovarian Stimulation Without Exogenous Pituitary Modulators.
    Zhu X; Ye J; Fu Y
    Front Endocrinol (Lausanne); 2020; 11():487. PubMed ID: 32903567
    [No Abstract]   [Full Text] [Related]  

  • 31. Impact of 'LH activity' supplementation on serum progesterone levels during controlled ovarian stimulation: a systematic review.
    Hugues JN
    Hum Reprod; 2012 Jan; 27(1):232-43. PubMed ID: 22081246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant luteinizing hormone priming in multiple follicular stimulation for in-vitro fertilization in downregulated patients.
    Lisi F; Caserta D; Montanino M; Berlinghieri V; Bielli W; Carfagna P; Carra MC; Costantino A; Lisi R; Poverini R; Ciardo F; Rago R; Marci R; Moscarini M
    Gynecol Endocrinol; 2012 Sep; 28(9):674-7. PubMed ID: 22313135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fresh blastocyst transfer as a clinical approach to overcome the detrimental effect of progesterone elevation at hCG triggering: a strategy in the context of the Italian law.
    Corti L; Papaleo E; Pagliardini L; Rabellotti E; Molgora M; La Marca A; Vigano P; Candiani M
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):73-7. PubMed ID: 24012449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH.
    Peñarrubia J; Fábregues F; Creus M; Manau D; Casamitjana R; Guimerá M; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2003 Dec; 18(12):2689-97. PubMed ID: 14645193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LH improves early follicular recruitment in women over 38 years old.
    Gómez-Palomares JL; Acevedo-Martín B; Andrés L; Ricciarelli E; Hernández ER
    Reprod Biomed Online; 2005 Oct; 11(4):409-14. PubMed ID: 16274596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The influence of exogenous LH/hCG activity on serum progesterone levels on the day of hCG administration in in vitro fertilization].
    Sebag-Peyrelevade S; El Hachem H; Gallot V; Genro VK; Fanchin R
    J Gynecol Obstet Biol Reprod (Paris); 2015 Jun; 44(6):524-31. PubMed ID: 25236690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits of luteinizing hormone activity in ovarian stimulation for IVF.
    Venetis CA; Kolibianakis EM; Tarlatzi TB; Tarlatzis BC
    Reprod Biomed Online; 2009; 18 Suppl 2():31-6. PubMed ID: 19406029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH.
    Nakagawa K; Ohgi S; Nakashima A; Horikawa T; Sugiyama R; Saito H
    J Assist Reprod Genet; 2008 Aug; 25(8):359-64. PubMed ID: 18752065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation.
    Humaidan P; Bungum L; Bungum M; Andersen CY
    Hum Reprod; 2002 Aug; 17(8):2016-21. PubMed ID: 12151430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live-birth rates after HP-hMG stimulation in the long GnRH agonist protocol: association with mid-follicular hCG and progesterone concentrations, but not with LH concentrations.
    Arce JC; Smitz J
    Gynecol Endocrinol; 2013 Jan; 29(1):46-50. PubMed ID: 22809021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.